Abstract P6-08-10: Prospective study of the impact of the Prosigna™ assay on adjuvant clinical decision-making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer: A GEICAM study

Clinical Decision ◽

Node Negative ◽

P198 Prospective trans-GEICAM study of the impact of the 21-gene recurrence score assay and traditional clinico-pathological factors on clinical decision making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer

The Breast ◽

10.1016/s0960-9776(11)70139-4 ◽

2011 ◽

Vol 20 ◽

pp. S43 ◽

Cited By ~ 3

Author(s):

J. Albanell ◽

R. Colomer ◽

M. Ruiz-Borrego ◽

E. Alba ◽

J.A. García Saenz ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Recurrence Score ◽

Clinical Decision ◽

Node Negative ◽

Prospective Study of the Effect of the 21-Gene Assay on Adjuvant Clinical Decision-Making in Japanese Women With Estrogen Receptor-Positive, Node-Negative, and Node-Positive Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2013.10.017 ◽

2014 ◽

Vol 14 (3) ◽

pp. 191-197 ◽

Cited By ~ 28

Author(s):

Hideko Yamauchi ◽

Chizuko Nakagawa ◽

Hiroyuki Takei ◽

Calvin Chao ◽

Carl Yoshizawa ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Prospective Study ◽

Clinical Decision ◽

Node Negative ◽

Gene Assay ◽

Positive Breast Cancer

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer

Annals of Oncology ◽

10.1093/annonc/mdr278 ◽

2012 ◽

Vol 23 (3) ◽

pp. 625-631 ◽

Cited By ~ 82

Author(s):

J. Albanell ◽

A. González ◽

M. Ruiz-Borrego ◽

E. Alba ◽

J.A. García-Saenz ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Recurrence Score ◽

Clinical Decision ◽

Clinicopathological Factors ◽

Node Negative ◽

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients

Breast Cancer Research and Treatment ◽

10.1007/s10549-013-2603-1 ◽

2013 ◽

Vol 140 (1) ◽

pp. 83-92 ◽

Cited By ~ 27

Author(s):

Salomon M. Stemmer ◽

Shmuel H. Klang ◽

Noa Ben-Baruch ◽

David B. Geffen ◽

Mariana Steiner ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Recurrence Score ◽

Clinical Decision ◽

Breast Cancer Patients ◽

The Impact ◽

Positive Breast Cancer

Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer

Current Medical Research and Opinion ◽

10.1185/03007995.2015.1037730 ◽

2015 ◽

Vol 31 (6) ◽

pp. 1129-1137 ◽

Cited By ~ 21

Author(s):

Miguel Martín ◽

Milagros González-Rivera ◽

Serafín Morales ◽

Juan de la Haba-Rodriguez ◽

Lucía González-Cortijo ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Early Stage ◽

Growth Factor Receptor ◽

Clinical Decision ◽

Node Negative ◽

Epidermal Growth ◽

Prospective Evaluation of Two Multi-Gene Assays in Node-Negative, Estrogen Receptor-Positive (Er+) Breast Cancer Patients to Aid Adjuvant Clinical Decision Making in a Community-Based Study

Annals of Oncology ◽

10.1093/annonc/mdu327.28 ◽

2014 ◽

Vol 25 ◽

pp. iv94

Author(s):

E. Martinez de Dueñas ◽

A. Lluch-Hernandez ◽

A. Llombart ◽

A. Rodriguez-Lescure ◽

D. Salas ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Clinical Decision ◽

Prospective Evaluation ◽

Breast Cancer Patients ◽

Community Based ◽

Node Negative ◽

Estrogen Receptor Positive

Prospective Clinical Utility Study of the Use of the 21‐Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor‐Positive Early Invasive Breast Cancer: Results From the SWITCH Study

The Oncologist ◽

10.1634/theoncologist.2014-0467 ◽

2015 ◽

Vol 20 (8) ◽

pp. 873-879 ◽

Cited By ~ 26

Author(s):

Joseph Gligorov ◽

Xavier B. Pivot ◽

William Jacot ◽

Hervé L. Naman ◽

Dominique Spaeth ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Invasive Breast Cancer ◽

Clinical Utility ◽

Clinical Decision ◽

Gene Assay ◽

Switch Study

Clinical decision making in postmastectomy radiotherapy in node negative breast cancer

ecancermedicalscience ◽

10.3332/ecancer.2018.874 ◽

2018 ◽

Vol 12 ◽

Cited By ~ 1

Author(s):

Rodrigo Barrientos ◽

Suraj Samtani ◽

Michael Frelinghuysen ◽

Camilo Sotomayor ◽

Juan Guillermo Gormaz ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Clinical Decision ◽

Postmastectomy Radiotherapy ◽

Node Negative ◽

Node Negative Breast Cancer

Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report

Journal of Personalized Medicine ◽

10.3390/jpm2030071 ◽

2012 ◽

Vol 2 (3) ◽

pp. 71-76

Author(s):

Steven R. Schuster ◽

Barbara A. Pockaj ◽

Mary R. Bothe ◽

Paru S. David ◽

Donald W. Northfelt

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Decision Making ◽

Expression Profiling ◽

Clinical Utility ◽

Early Stage ◽

Clinical Decision ◽

Node Negative ◽

Node Negative Breast Cancer

P202 Gross financial evaluation of the application of the 21-gene assay Oncotype DX for adjuvant chemotherapy decision-making in estrogen receptor-positive node negative breast cancer in Greece

The Breast ◽

10.1016/s0960-9776(11)70143-6 ◽

2011 ◽

Vol 20 ◽

pp. S44 ◽

Cited By ~ 1

Author(s):

L. Liaropoulos ◽

P. Galanis ◽

D. Kaitelidou ◽

D. Rovithis ◽

O. Siskou ◽

...

Keyword(s):

Breast Cancer ◽

Decision Making ◽

Estrogen Receptor ◽

Adjuvant Chemotherapy ◽

Oncotype Dx ◽

Financial Evaluation ◽

Node Negative ◽

Gene Assay ◽

Estrogen Receptor Positive